Intravenous Infusion of CAP-1002 in Patients With COVID-19
Clinical trial NCT04623671 · COMPLETED
Trial details
- NCT number
- NCT04623671
- Sponsor
- Capricor Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-15
- Primary completion
- 2022-02-04
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.